News & MediaLatest news FEATURED ARTICLE News & Media Cagent Vascular Announces Landmark Peer-Reviewed Data Demonstrating Safety and Efficacy of Serration Remodeling Therapy™ in the Most Challenging Arteries Below-the-Ankle Read more → Meg McConnell 5/26/20 Meg McConnell 5/26/20 The Serranator to be featured in the upcoming Limb Salvage Issue of Endovascular Today Read More Meg McConnell 5/6/20 Meg McConnell 5/6/20 The Serranator is featured in the Endovascular Today – Limb Salvage Issue Read More Meg McConnell 4/23/20 Meg McConnell 4/23/20 Cagent Vascular Announces FDA 510(k) Clearance for its Serranator Device for the Infrapopliteal Indication and Completion of its PRELUDE-BTK Clinical Trial Enrollment Read More Meg McConnell 1/7/20 Meg McConnell 1/7/20 Cagent Vascular Initiates Enrollment of PRELUDE-BTK Study Using Serranator Device Read More Meg McConnell 10/9/18 Meg McConnell 10/9/18 Cagent Vascular Appoints Medical Device Industry Veteran Brian Walsh as Chairman of the Board Read More Meg McConnell 11/20/17 Meg McConnell 11/20/17 Cagent Vascular announce CE Mark of SERRANATOR®, next generation device for vessel dilatation in peripheral artery disease interventions Read More Meg McConnell 6/5/17 Meg McConnell 6/5/17 Cagent Vascular Completes Enrollment of PRELUDE Study Using Serranator Device Read More Newer Posts
Meg McConnell 5/26/20 Meg McConnell 5/26/20 The Serranator to be featured in the upcoming Limb Salvage Issue of Endovascular Today Read More
Meg McConnell 5/6/20 Meg McConnell 5/6/20 The Serranator is featured in the Endovascular Today – Limb Salvage Issue Read More
Meg McConnell 4/23/20 Meg McConnell 4/23/20 Cagent Vascular Announces FDA 510(k) Clearance for its Serranator Device for the Infrapopliteal Indication and Completion of its PRELUDE-BTK Clinical Trial Enrollment Read More
Meg McConnell 1/7/20 Meg McConnell 1/7/20 Cagent Vascular Initiates Enrollment of PRELUDE-BTK Study Using Serranator Device Read More
Meg McConnell 10/9/18 Meg McConnell 10/9/18 Cagent Vascular Appoints Medical Device Industry Veteran Brian Walsh as Chairman of the Board Read More
Meg McConnell 11/20/17 Meg McConnell 11/20/17 Cagent Vascular announce CE Mark of SERRANATOR®, next generation device for vessel dilatation in peripheral artery disease interventions Read More
Meg McConnell 6/5/17 Meg McConnell 6/5/17 Cagent Vascular Completes Enrollment of PRELUDE Study Using Serranator Device Read More